Cytosorbents Corporation (NASDAQ:CTSO) Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Amy Vogel – Investor Relations Phillip Chan – Chief Executive Officer Kathleen Bloch – Chief Financial Officer Christian Steiner – Executive Vice President-Sales and Marketing and Managing Director-Cytosorbents Europe GmbH Christopher Cramer – Vice President-Business Development Efthymios Deliargyris – Chief Medical Officer Vincent Capponi – Chief Operating Officer and President Mike Gibson ...

CytoSorbents Corporation Annual Shareholders Meeting June 7, 2022 AGAAGAAAAAAAAAAAAAAAAA Safe Harbor Statement Statements in this presentation regarding CytoSorbents Corporation and its operating subsidiaries CytoSorbents Medical, Inc and CytoSorbents Europe GmbH that are not historical facts are forwardlooking statements and are subject to risks and uncertainties that could cause actual future events or results to differ materially from such statements. Any such forward-looking statements are made pursuant ...

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2022 Earnings Conference Call May 3, 2022 4:30 PM ET Company Participants Terri Anne Powers - Vice President, Investor Relations & Corporate Communications Phillip Chan - Chief Executive Officer Vincent Capponi - President & Chief Operating Officer Kathleen Bloch - Chief Financial Officer Christian Steiner - Executive Vice President, Sales & Marketing and Managing Director of Cytosorbents Europe Christopher Cramer - Vice President, Business Development Efthymios Del ...

| --- | --- | --- | --- | |-------|-------|-------|---------------------------------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | First Quarter 2022 Earnings Conference Call | | | | | CytoSorbents Corporation | | | | | May 3, 2022 | Conference Call Participants Moderator: Terri Anne Powers CytoSorbents Corporation Phillip Chan, MD, PhD – Chief Executive Officer Vincent Capponi, MS – President and Chief Operating Officer Kathleen Bloch, MBA, CPA – Chief Financial Officer Efthymios " ...

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2021 Earnings Conference Call March 8, 2022 4:30 PM ET Company Participants Terri Anne Powers - Vice President, Investor Relations and Corporate Communications Phillip Chan - Chief Executive Officer Vincent Capponi - President and Chief Operating Officer Kathleen Bloch - Chief Financial Officer Efthymios Deliargyris - Chief Medical Officer Christian Steiner - Executive Vice President, Sales and Marketing and Managing Director, CytoSorbents Europe Christopher Cramer ...

HELPING TO TREAT INFLAMMATION AND DEADLY CONDITIONS IN INTENSIVE CARE AND CARDIAC SURGERY CytoSorbents Corporation - NASDAQ: CTSO SVB Leerink Global Healthcare Conference – February 2022 Safe Harbor Statement This presentation contains "forward-looking statements" pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or ach ...

CytoSorbents Corporation (NASDAQ:CTSO) Q3 2021 Earnings Conference Call November 4, 2021 4:30 PM ET Company Participants Terri Powers - VP of IR & Corporate Communications Phillip Chan - CEO Christian Steiner - EVP of Sales & Marketing Efthymios Deliargyris - Chief Medical Officer Kathy Bloch - CFO Conference Call Participants Priya Sachdeva - SVB Leerink Bryan Bergin - Cowen Operator Good afternoon. And welcome to the CytoSorbents' Third Quarter 2021 Financial and Operating Results Conference Call. At this ...

CytoSorbents Corporation (NASDAQ:CTSO) Q2 2021 Earnings Conference Call August 3, 2021 4:30 PM ET Company Participants Terri Anne Powers - VP, IR and Corporate Communications Phillip Chan - Chief Executive Officer Efthymios Deliargyris - Chief Medical Officer Kathleen Bloch - Chief Financial Officer Christian Steiner - Executive Vice President, Sales and Marketing, Managing Director, CytoSorbents Europe GmbH Conference Call Participants Danielle Antalffy - SVB Leerink Anthony Petrone - Jefferies Andrew D'Si ...

CytoSorbents Corporation (NASDAQ:CTSO) Q1 2021 Earnings Conference Call May 4, 2021 4:45 PM ET Company Participants Amy Vogel - Investor Relations Phillip Chan - Chief Executive Officer Efthymios Deliargyris - Chief Medical Officer Kathleen Bloch - Chief Financial Officer Christian Steiner - Executive Vice President, Sales and Marketing, Managing Director, CytoSorbents Europe GmbH Conference Call Participants Anthony Petrone - Jefferies Josh Jennings - Cowen Danielle Antalffy - SVB Leerink Andrew D'Silva - ...

Cytosorbents Corporation (NASDAQ:CTSO) Q4 2020 Earnings Conference Call February 9, 2021 3:15 PM ET Company Participants Amy Vogel – Investor Relations Phillip Chan – Chief Executive Officer Efthymios Deliargyris – Chief Medical Officer Kathleen Bloch – Chief Financial Officer Christian Steiner – Executive Vice President-Sales and Marketing and Managing Director-CytoSorbents Europe Gmbh Vincent Capponi – President and Chief Operating Officer Christopher Cramer – Vice President-Business Development Conferenc ...